Restenosis in coronary bare metal stents. Importance of time to follow-up: A comparison of coronary angiograms 6 months and 4 years after implantation

Scandinavian Cardiovascular Journal

Volumn 43, Issue 2, 2009, Pages 87-93

  Jørgensen, Erik ^a   Helqvist, Steffen ^a   Kløvgaard, Lene ^a   Kastrup, Jens ^a   Clemmensen, Peter ^a   Holmvang, Lene ^a   Engstrm, Thomas ^a   Saunamaki, Kari ^a   Kelbæk, Henning ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Angiography; Coronary stents; Instent restenosis; Long term follow up

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; BLOOD VESSEL; COHORT ANALYSIS; CORONARY ARTERY; CORONARY STENT; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RESTENOSIS; SURVIVAL RATE; TISSUE REACTION; AGED; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; DISEASE FREE SURVIVAL; HEART INFARCTION; HYPERPLASIA; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROSTHESIS; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; REMISSION; STENT; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

METAL;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERPLASIA; KAPLAN-MEIERS ESTIMATE; MALE; METALS; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSTHESIS DESIGN; REMISSION, SPONTANEOUS; STENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 65449158010     PISSN: 14017431     EISSN: 16512006     Source Type: Journal    
DOI: 10.1080/14017430802582602     Document Type: Article

References (23)

1. Serruys PW, de Jaegere P, Kiemeneij F, Macaya C, Rutsch W, Heyndrickx G, et al. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med. 1994;331:489-95.
2. Fischman DL, Leon MB, Baim DS, Schatz RA, Savage MP, Penn I, et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med. 1994;331:496-501.
3. de Jaegere P, Mudra H, Figulla H, Almagor Y, Doucet S, Penn I, et al. IVUS guided optimised stent deployment: Immediate and 6 months clinical angiographic results from Multicenter Ultrasound Stenting in Coronaries study (MUSIC). Eur Heart J. 1998;19:1214-23.
4. Lansky AJ, Roubin GS, O'Shaughnessy CD, Moore PB, Dean LS, Raizner AE, et al. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses. Circulation. 2000;102:1364-8.
5. Kimura T, Yokoi H, Nakagawa Y, Tamura T, Kaburagi S, Sawada Y, et al. Three-year follow-up after implantation of metallic coronary-artery stents. N Engl J Med. 1996;334: 561-6.
6. Laham RJ, Carrozza JP, Berger C, Cohen DJ, Kuntz RE, Baim DS. Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: Paucity of late clinical stent-related problems. J Am Coll Cardiol. 1996;28:820-6.
7. Kiemeneij F, Serruys PW, Macaya C, Rutsch W, Heyndrickx G, Albertsson P, et al. Continued benefit of coronary stenting versus balloon angioplasty: Five-year clinical follow-up of Benestent-I trial. J Am Coll Cardiol. 2001;37:1598-603.
8. Nakamura S, Colombo A, Gaglione A, Almagor Y, Goldberg SL, Maiello L, et al. Intracoronary ultrasound observations during stent implantation. Circulation. 1994;89:2026-34.
9. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de nove native coronary artery lesions: A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med. 2002;346:1773-80.
10. Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease: A randomized controlled trial. JAMA. 2005;294:1215-23.
11. Kelbaek H, Helqvist S, Thuesen L, Kløvgaard L, Jørgensen E, Saunamæki K, et al. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial. J Am Coll Cardiol. 2008;51:2011-6.
12. Kelbæk H, Thuesen L, Helqvist S, Clemmensen P, Kløvgaard L, Kaltoft A, et al. Drug-eluting versus bare-metal stents in patients with ST-segment elevation myocardial infarction. Circulation. (in press).
13. Jørgensen E, Ripa RS, Helqvist S, Wang Y, Johnsen HE, Grande P, et al. Instent neo-intimal hyperplasia after stem cell mobilization by granulocyte-colony stimulating factor. Preliminary intracoronary ultrasound results from a double-blind randomized placebo-controlled study of patients treated with percutaneous coronary intervention for ST-Elevation Myocardial Infarction (STEMMI Trial). Int J Cardiol. 2006;111: 174-7.
14. Jørgensen E, Kelbæk H, Helqvist S, Jensen GV, Saunamäki K, Kastrup J, et al. Predictors of coronary in-stent restenosis. Importance of angiotensin converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors. J Am Coll Cardiol. 2001;38:1434-9.
15. Jørgensen E, Kelbæk H, Helqvist S, Jensen GV, Saunamaki K, Kastrup J, et al. Low restenosis rate of the NIR coronary stent. Results of the DANSTENT study: A randomised trial comparing a first with a second generation stent. Am Heart J. 2003;145:e5.
16. Van Weert AWM, LesperanceJ, ReiberJHC. Standardization of central off-line quantitative image analysis: Implications from experiences with quantitative coronary angiography. Heart Drug. 2001;1:/44-51.
17. Schatz RA, Palmaz JC, Tio FO, Garcia F, Garcia O, Reuter SR. Balloon expandable stents in the adult dog. Circulation. 1987;76:450-7.
18. Robinson KA, Roubin GS, King SB 3rd. Long-term intracoronary stent placement: Arteriographic and histologic results after 7 years in a dog model. Cathet Cardiovasc Diagn. 1996;38:32-7.
19. Nobuyoshi M, Kimura T, Ohishi H, Horiuchi H, Nosaka H, Hamasaki N, et al. Restenosis after percutaneous transluminal coronary angioplasty: Pathologic observations in 20 patients. J Am Coll Cardiol. 1991;17:433-9.
20. Farb A, Kolodgie FD, Hwang H-D, Burke AP, Tefera K, Weber DK, et al. Extracellular matrix changes in the stented human coronary arteries. Circulation. 2004;110:940-7.
21. Mauri L, Orav EJ, Kuntz RE. Late loss in lumen diameter and binary restenosis for drug-eluting stent comparison. Circulation. 2005;111:3435-42.
22. Windecker S, Remondino A, Eberli FR, Jüni P, Räber L, Wenaweser P, et al. Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Eng J Med. 2005; 353:653-62.
23. Morice MC, Colombo A, Meier B, Serruys P, Tanburino C, Guagliami G, et al. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions. The REALITY Trial: A randomized controlled trial. JAMA. 2006;295:895-904. 24. Bech GJ, De Bruyne B, Pijls NH, de Muinck ED, Hoorntje JC, Escaned J, et al. Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: A randomized trial. Circulation. 2001;103:2928-34.